These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2643232)

  • 1. Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody.
    Reed MH; Shapiro ME; Strom TB; Milford EL; Carpenter CB; Weinberg DS; Reimann KA; Letvin NL; Waldmann TA; Kirkman RL
    Transplantation; 1989 Jan; 47(1):55-9. PubMed ID: 2643232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.
    Brown PS; Parenteau GL; Dirbas FM; Garsia RJ; Goldman CK; Bukowski MA; Junghans RP; Queen C; Hakimi J; Benjamin WR
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2663-7. PubMed ID: 2011577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantation.
    Cooper MM; Robbins RC; Goldman CK; Mirzadeh S; Brechbiel MW; Stone CD; Gansow OA; Clark RE; Waldmann TA
    Transplantation; 1990 Nov; 50(5):760-5. PubMed ID: 2238051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of graft survival in primate allograft transplantation by yttrium-90-labeled anti-Tac in conjunction with granulocyte colony-stimulating factor.
    Parenteau GL; Dirbas FM; Garmestani K; Brechbiel MW; Bukowski MA; Goldman CK; Clark R; Gansow OA; Waldmann TA
    Transplantation; 1992 Dec; 54(6):963-8. PubMed ID: 1281566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TAC MOAB prolongs renal allografts in cynomolgus monkeys.
    Reed MH; Shapiro ME; Strom TB; Carpenter CB; Letvin NL; Reimann K; Weinberg DS; Waldmann TA; Kirkman RL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1028-30. PubMed ID: 2650064
    [No Abstract]   [Full Text] [Related]  

  • 6. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
    Tinubu SA; Hakimi J; Kondas JA; Bailon P; Familletti PC; Spence C; Crittenden MD; Parenteau GL; Dirbas FM; Tsudo M
    J Immunol; 1994 Nov; 153(9):4330-8. PubMed ID: 7930631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of a primate model of renal transplantation in the development of new monoclonal antibodies.
    Shapiro ME; Reed MH; Strom TB; Carpenter CB; Milford EL; Kirkman RL
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):58-60. PubMed ID: 2816938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
    Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
    Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
    Kirkman RL; Shapiro ME; Carpenter CB; McKay DB; Milford EL; Ramos EL; Tilney NL; Waldmann TA; Zimmerman CE; Strom TB
    Transplantation; 1991 Jan; 51(1):107-13. PubMed ID: 1846250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys.
    Hakimi J; Chizzonite R; Luke DR; Familletti PC; Bailon P; Kondas JA; Pilson RS; Lin P; Weber DV; Spence C
    J Immunol; 1991 Aug; 147(4):1352-9. PubMed ID: 1869828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of primate renal allografts with anti-Tac monoclonal antibody.
    Reed MH; Shapiro ME; Strom TB; Milford EL; Carpenter CB; Letvin NL; Waldmann TA; Kirkman RL
    Curr Surg; 1988; 45(1):28-30. PubMed ID: 3126026
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic use of monoclonal anti-IL-2 receptor antibody in cadaveric renal transplantation.
    Carpenter CB; Kirkman RL; Shapiro ME; Milford EL; Tiney NL; Waldmann TA; Zimmerman CE; Ramos EL; Strom TB
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):54-7. PubMed ID: 2683758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
    Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody.
    Ramos EL; Milford EL; Kirkman RL; Tilney NL; Strom TB; Shapiro ME; Waldmann TA; Wood IG; Rollins MR; Carpenter CB
    Transplantation; 1989 Sep; 48(3):415-20. PubMed ID: 2571203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.
    Ueda H; Hancock WW; Cheung YC; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
    Transplantation; 1990 Oct; 50(4):545-50. PubMed ID: 2219270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
    Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
    Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At.
    Wesley JN; McGee EC; Garmestani K; Brechbiel MW; Yordanov AT; Wu C; Gansow OA; Eckelman WC; Bacher JD; Flynn M; Goldman CK; MacLin M; Schwartz UP; Jackson-White T; Phillip CM; Decker J; Waldmann TA
    Nucl Med Biol; 2004 Apr; 31(3):357-64. PubMed ID: 15028248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys.
    Mourad GJ; Preffer FI; Wee SL; Powelson JA; Kawai T; Delmonico FL; Knowles RW; Cosimi AB; Colvin RB
    Transplantation; 1998 Mar; 65(5):632-41. PubMed ID: 9521196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.
    Cosimi AB; Delmonico FL; Wright JK; Wee SL; Preffer FI; Jolliffe LK; Colvin RB
    Surgery; 1990 Aug; 108(2):406-13; discussion 413-4. PubMed ID: 2382234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.